Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

A dynamic neural network model for predicting risk of Zika in real time.

Akhtar M, Kraemer MUG, Gardner LM.

BMC Med. 2019 Sep 2;17(1):171. doi: 10.1186/s12916-019-1389-3.

2.

Travel Surveillance and Genomics Uncover a Hidden Zika Outbreak during the Waning Epidemic.

Grubaugh ND, Saraf S, Gangavarapu K, Watts A, Tan AL, Oidtman RJ, Ladner JT, Oliveira G, Matteson NL, Kraemer MUG, Vogels CBF, Hentoff A, Bhatia D, Stanek D, Scott B, Landis V, Stryker I, Cone MR, Kopp EW 4th, Cannons AC, Heberlein-Larson L, White S, Gillis LD, Ricciardi MJ, Kwal J, Lichtenberger PK, Magnani DM, Watkins DI, Palacios G, Hamer DH; GeoSentinel Surveillance Network, Gardner LM, Perkins TA, Baele G, Khan K, Morrison A, Isern S, Michael SF, Andersen KG.

Cell. 2019 Aug 22;178(5):1057-1071.e11. doi: 10.1016/j.cell.2019.07.018.

PMID:
31442400
3.

Update to the study protocol, including statistical analysis plan, for the multicentre, randomised controlled OuTSMART trial: a combined screening/treatment programme to prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies.

Stringer D, Gardner LM, Peacock JL, Rebollo-Mesa I, Hilton R, Shaw O, Baker R, Clark B, Thuraisingham RC, Buckland M, Picton M, Worthington J, Borrows R, Briggs D, Shah S, Shiu KY, McCullough K, Phanish M, Hegarty J, Stoves J, Ahmed A, Ayub W, Horne R, McCrone P, Kelly J, Murphy C, Dorling A.

Trials. 2019 Aug 5;20(1):476. doi: 10.1186/s13063-019-3602-2.

4.

Correlates of DSM-5 Autism Spectrum Disorder Levels of Support Ratings in a Clinical Sample.

Gardner LM, Campbell JM, Keisling B, Murphy L.

J Autism Dev Disord. 2018 Oct;48(10):3513-3523. doi: 10.1007/s10803-018-3620-z.

PMID:
29845346
5.

Inferring the risk factors behind the geographical spread and transmission of Zika in the Americas.

Gardner LM, Bóta A, Gangavarapu K, Kraemer MUG, Grubaugh ND.

PLoS Negl Trop Dis. 2018 Jan 18;12(1):e0006194. doi: 10.1371/journal.pntd.0006194. eCollection 2018 Jan.

6.

Translation of Real-Time Infectious Disease Modeling into Routine Public Health Practice.

Muscatello DJ, Chughtai AA, Heywood A, Gardner LM, Heslop DJ, MacIntyre CR.

Emerg Infect Dis. 2017 May;23(5). doi: 10.3201/eid2305.161720.

7.

Zika virus in Pakistan: the tip of the iceberg?

Butt AM, Siddique S, Gardner LM, Sarkar S, Lancelot R, Qamar R.

Lancet Glob Health. 2016 Dec;4(12):e913-e914. doi: 10.1016/S2214-109X(16)30246-7. Epub 2016 Nov 1. No abstract available.

8.

Risk of global spread of Middle East respiratory syndrome coronavirus (MERS-CoV) via the air transport network.

Gardner LM, Chughtai AA, MacIntyre CR.

J Travel Med. 2016 Sep 5;23(6). pii: taw063. doi: 10.1093/jtm/taw063. Print 2016 Jun.

PMID:
27601536
9.

Global risk of Zika virus depends critically on vector status of Aedes albopictus.

Gardner LM, Chen N, Sarkar S.

Lancet Infect Dis. 2016 May;16(5):522-523. doi: 10.1016/S1473-3099(16)00176-6. Epub 2016 Mar 18. No abstract available.

PMID:
26997578
10.

A scenario-based evaluation of the Middle East respiratory syndrome coronavirus and the Hajj.

Gardner LM, Rey D, Heywood AE, Toms R, Wood J, Travis Waller S, Raina MacIntyre C.

Risk Anal. 2014 Aug;34(8):1391-400. doi: 10.1111/risa.12253. Epub 2014 Jul 14.

11.

Unanswered questions about the Middle East respiratory syndrome coronavirus (MERS-CoV).

Gardner LM, MacIntyre CR.

BMC Res Notes. 2014 Jun 11;7:358. doi: 10.1186/1756-0500-7-358.

12.

T cell targeted strategies for improved efficacy and safety of specific immunotherapy for allergic disease.

Rolland JM, Prickett S, Gardner LM, O'Hehir RE.

Antiinflamm Antiallergy Agents Med Chem. 2013;12(3):201-22.

PMID:
23597085
13.

Unique and cross-reactive T cell epitope peptides of the major Bahia grass pollen allergen, Pas n 1.

Etto T, de Boer C, Prickett S, Gardner LM, Voskamp A, Davies JM, O'Hehir RE, Rolland JM.

Int Arch Allergy Immunol. 2012;159(4):355-66. doi: 10.1159/000338290. Epub 2012 Jul 25.

PMID:
22832594
14.

A predictive spatial model to quantify the risk of air-travel-associated dengue importation into the United States and europe.

Gardner LM, Fajardo D, Waller ST, Wang O, Sarkar S.

J Trop Med. 2012;2012:103679. doi: 10.1155/2012/103679. Epub 2012 Mar 14.

15.

Functional regulatory T cells and allergen immunotherapy.

Rolland JM, Gardner LM, O'Hehir RE.

Curr Opin Allergy Clin Immunol. 2010 Dec;10(6):559-66. doi: 10.1097/ACI.0b013e32833ff2b2. Review.

PMID:
20859202
16.

House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells.

O'Hehir RE, Gardner LM, de Leon MP, Hales BJ, Biondo M, Douglass JA, Rolland JM, Sandrini A.

Am J Respir Crit Care Med. 2009 Nov 15;180(10):936-47. doi: 10.1164/rccm.200905-0686OC. Epub 2009 Aug 20.

PMID:
19696440
17.

Allergen-related approaches to immunotherapy.

Rolland JM, Gardner LM, O'Hehir RE.

Pharmacol Ther. 2009 Mar;121(3):273-84. doi: 10.1016/j.pharmthera.2008.11.007. Epub 2008 Dec 7. Review.

PMID:
19111571
18.
19.

The short-term effects of prescribed burning on biomass removal and the release of nitrogen and phosphorus in a treatment wetland.

White JR, Gardner LM, Sees M, Corstanje R.

J Environ Qual. 2008 Oct 23;37(6):2386-91. doi: 10.2134/jeq2008.0019. Print 2008 Nov-Dec.

PMID:
18948493
20.

Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism.

Jacobson SG, Cideciyan AV, Aleman TS, Sumaroka A, Roman AJ, Gardner LM, Prosser HM, Mishra M, Bech-Hansen NT, Herrera W, Schwartz SB, Liu XZ, Kimberling WJ, Steel KP, Williams DS.

Hum Mol Genet. 2008 Aug 1;17(15):2405-15. doi: 10.1093/hmg/ddn140. Epub 2008 May 7.

21.

Retinal disease in Usher syndrome III caused by mutations in the clarin-1 gene.

Herrera W, Aleman TS, Cideciyan AV, Roman AJ, Banin E, Ben-Yosef T, Gardner LM, Sumaroka A, Windsor EA, Schwartz SB, Stone EM, Liu XZ, Kimberling WJ, Jacobson SG.

Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2651-60. doi: 10.1167/iovs.07-1505. Epub 2008 Feb 15.

PMID:
18281613
22.

The effect of single versus multiple sets on strength.

Kelly SB, Brown LE, Coburn JW, Zinder SM, Gardner LM, Nguyen D.

J Strength Cond Res. 2007 Nov;21(4):1003-6.

PMID:
18076273
23.

Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations.

Aleman TS, Cideciyan AV, Windsor EA, Schwartz SB, Swider M, Chico JD, Sumaroka A, Pantelyat AY, Duncan KG, Gardner LM, Emmons JM, Steinberg JD, Stone EM, Jacobson SG.

Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1319-29.

24.

Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures.

Roman AJ, Schwartz SB, Aleman TS, Cideciyan AV, Chico JD, Windsor EA, Gardner LM, Ying GS, Smilko EE, Maguire MG, Jacobson SG.

Exp Eye Res. 2005 Feb;80(2):259-72.

PMID:
15670804
25.
26.
27.

The hevein domain of the major latex-glove allergen Hev b 6.01 contains dominant T cell reactive sites.

de Silva HD, Gardner LM, Drew AC, Beezhold DH, Rolland JM, O'Hehir RE.

Clin Exp Allergy. 2004 Apr;34(4):611-8.

PMID:
15080815
28.
29.

Macular pigment and lutein supplementation in choroideremia.

Duncan JL, Aleman TS, Gardner LM, De Castro E, Marks DA, Emmons JM, Bieber ML, Steinberg JD, Bennett J, Stone EM, MacDonald IM, Cideciyan AV, Maguire MG, Jacobson SG.

Exp Eye Res. 2002 Mar;74(3):371-81.

PMID:
12014918
30.

The tumour suppressor gene maspin is differentially regulated in cytotrophoblasts during human placental development.

Dokras A, Gardner LM, Kirschmann DA, Seftor EA, Hendrix MJ.

Placenta. 2002 Apr;23(4):274-80.

PMID:
11969337
31.

Partial cytochrome b sequences for six Hymenoptera of the eastern United States.

Collins AM, Gardner LM.

J Hered. 2001 Nov-Dec;92(6):519-21.

PMID:
11948223
32.

Regulation of human cytotrophoblast morphogenesis by hepatocyte growth factor/scatter factor.

Dokras A, Gardner LM, Seftor EA, Hendrix MJ.

Biol Reprod. 2001 Oct;65(4):1278-88.

PMID:
11566754
33.

Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.

Seftor RE, Seftor EA, Koshikawa N, Meltzer PS, Gardner LM, Bilban M, Stetler-Stevenson WG, Quaranta V, Hendrix MJ.

Cancer Res. 2001 Sep 1;61(17):6322-7.

34.

Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome.

Aleman TS, Duncan JL, Bieber ML, de Castro E, Marks DA, Gardner LM, Steinberg JD, Cideciyan AV, Maguire MG, Jacobson SG.

Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1873-81.

PMID:
11431456
35.

Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry.

Hendrix MJ, Seftor EA, Meltzer PS, Gardner LM, Hess AR, Kirschmann DA, Schatteman GC, Seftor RE.

Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):8018-23. Epub 2001 Jun 19.

36.

Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).

Hess AR, Seftor EA, Gardner LM, Carles-Kinch K, Schneider GB, Seftor RE, Kinch MS, Hendrix MJ.

Cancer Res. 2001 Apr 15;61(8):3250-5.

37.

Molecular determinants of ovarian cancer plasticity.

Sood AK, Seftor EA, Fletcher MS, Gardner LM, Heidger PM, Buller RE, Seftor RE, Hendrix MJ.

Am J Pathol. 2001 Apr;158(4):1279-88.

38.

Down-regulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancer.

Kirschmann DA, Lininger RA, Gardner LM, Seftor EA, Odero VA, Ainsztein AM, Earnshaw WC, Wallrath LL, Hendrix MJ.

Cancer Res. 2000 Jul 1;60(13):3359-63.

39.

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ.

Am J Pathol. 1999 Sep;155(3):739-52.

40.

New technique for the cytologic identification of presumed Acanthamoeba from corneal epithelial scrapings.

Gardner LM, Mathers WD, Folberg R.

Am J Ophthalmol. 1999 Feb;127(2):207-9.

PMID:
10030566
41.
42.

Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).

Hendrix MJ, Seftor EA, Seftor RE, Kirschmann DA, Gardner LM, Boldt HC, Meyer M, Pe'er J, Folberg R.

Am J Pathol. 1998 Apr;152(4):855-63.

43.

Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.

Hendrix MJ, Seftor EA, Seftor RE, Gardner LM, Boldt HC, Meyer M, Pe'er J, Folberg R.

Lab Invest. 1998 Feb;78(2):153-63. Review.

PMID:
9484713
44.

Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy.

Mueller AJ, Bartsch DU, Folberg R, Mehaffey MG, Boldt HC, Meyer M, Gardner LM, Goldbaum MH, Pe'er J, Freeman WR.

Arch Ophthalmol. 1998 Jan;116(1):31-9.

PMID:
9445206
45.

The microcirculation of choroidal and ciliary body melanomas.

Folberg R, Mehaffey M, Gardner LM, Meyer M, Rummelt V, Pe'er J.

Eye (Lond). 1997;11 ( Pt 2):227-38. Review.

PMID:
9349418
46.

Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression.

Daniels KJ, Boldt HC, Martin JA, Gardner LM, Meyer M, Folberg R.

Lab Invest. 1996 Jul;75(1):55-66.

PMID:
8683940

Supplemental Content

Loading ...
Support Center